Increased osteoblastogenesis and decreased bone resorption protect against ovariectomy-induced bone loss in thrombospondin-2-null mice.
Although bone is composed primarily of extracellular matrix (ECM), the dynamic role that the ECM plays in regulating bone remodeling secondary to estrogen loss is relatively unexplored. Previous studies have shown that mice deficient in the matricellular protein thrombospondin-2 (TSP2-null) form excess endocortical bone; thus, we postulated that enhanced bone formation in TSP2-null mice could protect against ovariectomy (OVX)-induced bone loss. Wild-type (WT) OVX mice showed a significant loss of both midfemoral endocortical and proximal tibial trabecular bone, but OVX did not significantly alter TSP2-null bone. TSP2-null mice showed an increase in bone formation, as indicated by a 70% increase in serum osteocalcin two weeks post OVX and a two-fold increase in bone formation rate (BFR) five weeks post OVX as measured by dynamic histomorphometry. WT animals showed only a 20% increase in serum osteocalcin at two weeks and no change in BFR at five weeks. This increase in bone formation in TSP2-null OVX mice was accompanied by a three-fold increase in osteoprogenitor number. Although these results provide a partial explanation for the maintenance of bone geometry post-OVX, TSP2-null mice five weeks post-OVX also showed a significantly lower level of bone resorption than OVX WT mice, as determined by serum levels of the amino-terminal telopeptide of type I collagen (NTx). We conclude that the absence of TSP2 protects against OVX-induced bone loss by two complementary processes: increased formation and decreased resorption.
G161 400 N. Ingalls Bldg., Department of Orthopaedic Surgery, University of Michigan, Ann Arbor MI 48109, USA. kdhank@umich.edu
K D
KD
Hankenson
I E
IE
James
S
S
Apone
G B
GB
Stroup
S M
SM
Blake
X
X
Liang
M W
MW
Lark
P
P
Bornstein
D000818:Animals; D001835:Body Weight; D015519:Bone Density; D001862:Bone Resorption / Q000503:physiopathology*; D002454:Cell Differentiation; D004967:Estrogens / Q000172:deficiency; D005260:Female; D005269:Femur / Q000473:pathology / Q000503:physiopathology; D051379:Mice; D018345:Mice, Knockout; D023421:Models, Animal; D010006:Osteoblasts / Q000166:cytology*; D010012:Osteogenesis / Q000502:physiology*; D010052:Ovariectomy / Q000009:adverse effects*; D019699:Thrombospondins / Q000172:deficiency* / Q000235:genetics / Q000378:metabolism; D013977:Tibia / Q000473:pathology / Q000503:physiopathology; D000099262:Thrombospondin 2
D004967:Estrogens; D019699:Thrombospondins; D000099262:Thrombospondin 2